Recent studies have found an association between presence of apolipopr
otein E (APOE) epsilon 4 allele and Alzheimer's disease (AD). The pres
ent study compared the cumulative risk of primary progressive dementia
(PPD) in relatives of AD probands carrying at least one copy of the e
psilon 4 allele with the relatives of AD probands not carrying epsilon
4 and with relatives of non-demented controls. Our aim was to determi
ne whether the familial aggregation of PPD in relatives of AD probands
is primarily due to those carrying epsilon 4. Seventy-seven neuropath
ologically diagnosed AD patients were obtained as probands through our
Alzheimer's Disease Research Center Brain Bank. AD probands were geno
typed for APOE. As a comparison group, 198 non-demented probands were
also included. Through family informants, demographic and diagnostic d
ata were collected on 382 first-degree relatives (age greater than or
equal to 45 years) of AD probands and 848 relatives of the controls. W
e found that the cumulative risk of PPD in both relatives of AD proban
ds with and without the epsilon 4 allele was significantly higher than
that in the relatives of non-demented controls. However, the increase
d risk in the relatives of AD probands with the epsilon 4 allele was m
arginally, but not significantly, lower than the risk in the relatives
of probands without epsilon 4. A greater likelihood of death by heart
diseases over developing PPD in relatives of AD probands with epsilon
4 (3.1-fold increase) was found compared to relatives of probands wit
hout epsilon 4 (1.7-fold increase), especially prior to age 70, althou
gh the difference was not statistically significant. The increased fam
ilial risk for PPD in the relatives of AD probands with the APOE-epsil
on 4 allele relative to controls suggests that familial factors in add
ition to APOE-epsilon 4 are risk factors for AD. Differential censorsh
ip from increased mortality of heart diseases may have prevented a hig
her incidence of PPD among the relatives of probands with epsilon 4. (
C) 1996 Wiley-Liss, Inc.